Type 2 diabetes mellitus is associated with an increased risk of cognitive decline and dementia. Observational data suggest that hyperglycaemia, hypertension and dyslipidaemia might be involved in the causal pathway underlying this link, but data from the ACCORD MIND investigators challenge these findings. Why are the findings of observational and intervention studies so disconnected?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Strachan, M. W. J., Reynolds, R. M., Marioni, R. E. & Price J. F. Cognitive function, dementia and diabetes in the elderly. Nat. Rev. Endocrinol. 7, 108–114 (2011).
Ritchie, K. et al. Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ 341, c3885 (2010).
Kloppenburg, R. P., van den Berg, E., Kappelle, L. J. & Biessels, G. J. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur. J. Pharmacol. 585, 97–108 (2008).
Launer, L. J. et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomized open-label substudy. Lancet Neurol. 10, 969–977 (2011).
Williamson, J. D. et al. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels. A randomized clinical trial. JAMA Intern. Med. 174, 324–333 (2014).
Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358, 2545–2559 (2008).
ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus. N. Engl. J. Med. 362, 1563–1574 (2011).
ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N. Engl. J. Med. 362, 1575–1585 (2011).
McGuinness, B., Todd, S., Passmore, P. & Bullock, R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database of Systematic Reviews Issue 4. Art. No.: CD004034. http://dx.doi.org/10.1002/14651858.CD004034.pub3.
McGuinness, B., Craig, D., Bullock, R. & Passmore, P. Statins for the prevention of dementia. Cochrane Database of Systematic Reviews Issue 2. Art. No.: CD003160. http://dx.doi.org/10.1002/14651858.CD003160.pub2.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Strachan, M., Price, J. Cognitive decline and T2DM—a disconnect in the evidence?. Nat Rev Endocrinol 10, 258–260 (2014). https://doi.org/10.1038/nrendo.2014.38
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2014.38